Thousands at risk of blindness set to benefit from a new eye drug

Thousands at risk of blindness set to benefit from a new eye drug Brolucizumab, has now been approved by NHS chiefs for patients with wet age-related macular deterioration - a painless yet incurable eye disease that's the leading cause of blindness in over-55s. The Daily Mail